Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 280

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science

Megan Bowers & Mikayla Hellwich: MDMA History, Harm Reduction, and the Problem With Prohibition

Pα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly; Turnbull Doubles Down on BOL-148; Compass Talks Indication Expansion, Could VA Help?

From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT

Psychedelic Alpha Crossword: Summer 2026

Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation...

Delix Therapeutics Co-Founder Publishes Groundbreaking Study Demonstrating Therapeutic Potential for a...

Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) enter into Joint...

PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the...

COMPASS Pathways launches proposed public offering

Mystical Encounters, With and Without Drugs

How To Talk With Your Kids About Psychedelics

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in...

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to...

Red Light Holland and Halo Collective Create Red Light Oregon, Inc....

Load more

EDITOR PICKS

The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science

Megan Bowers & Mikayla Hellwich: MDMA History, Harm Reduction, and the...

Pα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly;...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©